Quantitative EEG- and EMG-analysis during electroconvulsive therapy

Quantitative EEG- and EMG-analysis during electroconvulsive therapy - Q-EEE (Quantitative EEG and EMG during ECT)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021609

Enrollment

Registered

2020-04-28

Start date

2019-08-24

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G40.2 F33.2

Interventions

Group 1: Patients who have a clinical indication for electroconvulsive therapy (ECT) either applied as series or as single maintenance ECT Group 2: Patients with focal epilepsy who are inpatients in t

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Signed informed consent - Clinical indication for electroconvulsive therapy

Exclusion criteria

Exclusion criteria: - Acute or chronic severe neurological disorder apart of epilepsy; - Acute or chronic severe systems disease; - dementia; - Organic affective disorder; - Substance abuse apart of nicotine; - Lack of insight to treatment and study or forced hospitalization as of laws of lower-saxonia for the mentally ill (§1906 BGB)

Design outcomes

Primary

Measure	Time frame
EEG frequency-domain analysis during electroconvulsive therapy compared with EEG frequency-domain analysis during spontaneous seizures	—

Secondary

Measure	Time frame
EMG analysis during electroconvuslvie therapy compared with EMG analysis during spontaneous seizures	—

Countries

Germany

Contacts

Public ContactCaspar Stephani

Universitätsklinikum Göttingen Klinik für Anästhesiologie Klinik für Klinische Neurophysiologie

CStephani@med.uni-goettingen.de+49-551-39-67744

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026